Enhancing Equine Wellbeing: MagnaWave PEMF for Horses with Equine Protozoal Myeloencephalitis (EPM)

Full Article on MagnaWave

Understanding EPM

Equine Protozoal Myeloencephalitis (EPM) is a severe and often debilitating condition affecting horses’ central nervous systems. Fortunately, MagnaWave offers a promising option for managing the recovery process in horses affected by EPM.

What is EPM?

EPM is a neurological disease caused predominantly by the protozoan Sarcocystis neurona. Protozoa are single-cell organisms with a nucleus that derive their nutrition from the host. Horses typically contract EPM through ingesting contaminated feed or water containing the protozoan. After ingestion, the protozoa multiply in extra-neural tissues and attack the central nervous system.

Symptoms of EPM can include:

• Muscle Atrophy

• Lameness

• Incoordination

• Behavioral Changes

These symptoms can severely impact a horse’s daily behavior and athletic abilities, making swift and effective treatment essential.

How MagnaWave Can Help

MagnaWave utilizes Pulsed Electromagnetic Field (PEMF) technology and offers a non-invasive method to help alleviate the discomfort and inflammation associated with EPM. PEMF can penetrate to the cellular level, enhancing membrane permeability and stimulating cellular metabolism.

The Lifecycle of EPM

In the United States, the opossum is the primary definitive host for Sarcocystis neurona. Opossums become infected by consuming tissue from an intermediate host that harbors the protozoan. The infected opossum sheds sporocysts in its feces. Horses ingest these sporocysts through contaminated feed or water, leaving them vulnerable to contracting EPM.

Benefits of Using MagnaWave for the Management of EPM

• Reduces Inflammation: MagnaWave can help lessen the mixed inflammatory response caused by the protozoa, providing relief to the horse.

• Pain Management: By alleviating discomfort, horses can experience a better quality of life during recovery.

• Improved Cellular Function: Enhanced membrane permeability can promote better absorption and utilization of prescribed medications, optimizing their effectiveness.

Long-Term Management and Support

Horses afflicted with EPM may never completely recover from the neurological damage caused by the disease, leading to lasting effects that can persist throughout their lives. As such, ongoing MagnaWave may be beneficial as a continuous care plan to help maintain comfort and general wellness.